Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating health service use among PrEP users in Washington DC

Official title: A Mixed Methods Study of the Association Between LAI PrEP Initiation and Adherence, and Utilization of Health and Social Support Services Among Key Populations in Washington DC

Run by Us Helping Us, People Into Living, Inc. · NCT06046079 · Data updated 2026-11-12

This study looks at how using PrEP affects the way people in Washington DC access health and social services over a year.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUs Helping Us, People Into Living, Inc.
Academic / other
Locations1 site (Washington D.C., District of Columbia)
StatusRecruiting
StartedAugust 25, 2023
Main results expectedJuly 3, 2025
Study endsJanuary 1, 2026
Registry record updatedMarch 10, 2025
Trial IDNCT06046079 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are HIV-negative individuals aged 18 and older residing in the Washington, DC metropolitan area, with either no prior PrEP use or currently on daily oral PrEP or LAI-PrEP.

Probably not a fit

Patients who are under 18 years old, do not reside in the Washington, DC area, or have a history of mental health conditions that prevent compliance may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore how the use of pre-exposure prophylaxis (PrEP) influences the utilization of various health and social services among individuals in Washington DC. The primary hypothesis is that individuals currently using PrEP will show higher engagement with sexual health services, psychosocial support, and other social resources compared to those who have never used PrEP. The study will follow participants over a 12-month period to assess these differences in service utilization. By focusing on a key population, the study seeks to provide insights into the broader impacts of PrEP on health behaviors and service engagement.

Why it matters

Potential benefit: If successful, this study could enhance understanding of how PrEP use can lead to increased access to essential health and social services for at-risk populations.

How similar studies have gone: While this study focuses on a specific population and context, similar studies have shown that PrEP can positively influence health service utilization, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age of 18 years or above;
* confirmed HIV-negative status;
* residence in the Washington, DC metropolitan area;
* one of the following PrEP profiles (PrEP naïve \[no history of any PrEP use in the past\] currently on daily oral PrEP or receiving LAI-PrEP).

Exclusion Criteria:

* being younger than18 years of age
* being unable to speak and/or read English
* a reported residence outside of the defined Washington, DC metropolitan area
* being unable or unwilling to provide written informed consent
* being unable to comply with the requirements of the protocol (i.e. persons with mental health conditions, persons who are intoxicated or incoherent for other reasons)
* evidence of suspected hepatoxicity

Where it's running

  • Us Helping Us, People into Living Inc
    Washington D.C., District of Columbia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.